John Hussman

Investor and economist known for his research-driven investment approach and his focus on identifying overvalued and undervalued securities based on market conditions.

Explore John Hussman's largest investments on Profit.com, including companies like Corcept Therapeutics Incorporated, United Natural Foods Inc, and Campbell’s Co, and their significance in his portfolio.

John Hussman’s portfolio updates are typically published quarterly through SEC 13F filings, which provide detailed information about their holdings, including recent buys and sells. Additionally, real-time updates on insider trades are available through Form 4 filings, offering a more timely view of their trading activity.

John Hussman currently invests in companies such as Corcept Therapeutics Incorporated, United Natural Foods Inc, and Campbell’s Co, focusing on sectors like Healthcare and Technology.

The largest holding in John Hussman’s portfolio is Corcept Therapeutics Incorporated, accounting for 1.10% of their total investments.

One of John Hussman’s most profitable investments is Praxis Precision Medicines Inc, which has generated a return of 216.03% over the past year.

As of 12 May 2026, John Hussman’s portfolio is valued at approximately $462.55M, based on the latest filings available on Profit.com.

Yes, you can use Profit.com to follow John Hussman’s portfolio and gain insights to build your own investment portfolio.

You can follow John Hussman’s portfolio updates on Profit.com, which provides notifications on the latest portfolio transactions as soon as they’re available.

Stay up-to-date with John Hussman’s latest trades by following their portfolio on Profit.com. Enable notifications to receive real-time alerts on their newest buy and sell transactions.